Download | < Back |
04 Jun 2016 | |
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated June 04, 2016 titled "Zydus receives approval from USFDA to initiate Phase 2 clinical trials of Saroglitazar in patients with Non-Alcoholic Steatohepatitis (NASH) of the liver in USA" | |
View all announcements for CADILA HEALTHCARE LTD. | Source: BSE India |